The judges selected Mareedi because of its novel “BYOD/non-wearable-dependent approach” to measure and monitor essential health biomarkers. The judges found Mareedi’s cutting edge features to be a compelling solution to help maintain visibility and increase reporting accuracy on SARS-CoV-2 infection rates across the country, as well as to ensure that all SARS-CoV-2 diagnostic tools can securely transmit test results to local and national public health authorities, health care providers, and patients, ensuring a timely public health response.
"[Mareedi] is rooted in credible academic research, has been under development for some time, and has successfully negotiated prior challenges to reach this point of sophistication.
The judges said that by “leveraging onboard sensors to obtain measures consistent with emerging approaches to sensor-based disease detection and proximity tracking, [...] Mareedi lends itself to broad, cross-platform adoption.” The judges also noted the crucial impact of Mareedi’s HulaScore, which provides users “with feedback and reward to reinforce app compliance and engagement.” The judges lauded Mareedi’s dashboard for its “compliance monitoring and data visualization” functionality, as well as Mareedi’s “use of standards [that] promote interoperability needed to scale.”
Mareedi will now advance to a 6-week TOPx (The Opportunity Project) virtual tech sprint facilitated by the U.S. Census Bureau to expedite further development starting in January 2021
"The ultimate result of both the Design-a-thon and TOPx technology sprints will be SARS-CoV-2 diagnostic tests that have built-in, automated, harmonized data capture and wireless transmission capabilities.
Mareedi is a secure wellness app to generate vital measurements such as pulse, respiratory sounds monitoring, contact tracing, and CDC COVID-19 questionnaire culminating in a daily health pass. Users simply place their finger over their smartphone's camera to record a 30-second video, which is then instantly analyzed by Mareedi’s innovative machine learning algorithms to produce the vitals; no wearable device is needed. Mareedi’s at-home collection method fosters accessibility, as 80% of the US population have smartphones. COVID-19 tests can be ordered directly from the app with positive results flagged. Local state apps can tie into Mareedi’s contact tracing features. States that have not yet availed of this service provided by Apple and Google can turn to Mareedi for quick contact tracing deployment. The anonymized data, including lab/home test results, biomarkers, self-reported data, will be pushed directly to WATERS - the FDA/HHS central data repository.
Mareedi has begun development for the inclusion of vaccination status on the daily health pass. Mareedi’s researchers are working non-stop to develop groundbreaking solutions to collect additional medical biomarkers, including:
- COVID detection algorithm
- Blood pressure
- Blood oxygen (SpO2)
- Heart disease screening
- Heart rate variability
- Respiratory rate
- Stress and mental health screening
- Optometry screen
- Bloodless labs such as hemoglobin, glucose, and pH
Mareedi will seek FDA approval in 2021.
COO at AIE Technology Solutions, Inc.
Schedule a 30-minute call